Tilray Brands, Inc. TLRY

Latest FY: 2026 Healthcare Drug Manufacturers - Specialty & Generic
Market Price $4.53
Market Cap $526.50M
P/E Ratio N/A
Quick Peer Compare (Healthcare):
Revenue (FY 2026) ↑11.5% YoY
$915.45M
3-Yr CAGR: 13.4%
Net Income ↑94.4% YoY
-$121.40M
Net Margin: -13.3%
Free Cash Flow ↑19.9% YoY
-$102.13M
FCF Yield: -19.40%
EPS (Diluted) ↑55.7% YoY
$-1.09
Basic: $-1.09
Return on Equity Efficiency
-7.6%
ROA: -5.2%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (TLRY)

All monetary values in millions ($M)
⚠️ YoY Data Quality Alert
  • FY 2018: Revenue YoY (+0.0%) is identical to Gross Profit YoY (+0.0%). Verify the underlying Revenue and Gross Profit values for FY 2018 and FY 2017.
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Div / Sh Div Yield Op. Cash Flow Free Cash Flow FCF YoY
FY 2017 $20.5M $11.4M $-6.0M
FY 2018 $20.5M 0.0% $11.4M $-7.8M 0.00% $-6.0M $-16.9M
FY 2019 $167.0M +713.0% $-23.5M $-321.2M -4,012.8% $-0.18 0.00% $-258.1M $-331.8M -1,861.8%
FY 2020 $210.5M +26.1% $24.7M $-271.1M +15.6% $-0.47 -161.1% 0.00% $-129.4M $-174.0M +47.6%
FY 2021 $513.1M +143.8% $123.2M $-367.4M -35.5% $-1.25 -166.0% 0.00% $-44.7M $-83.6M +52.0%
FY 2022 $628.4M +22.5% $116.8M $-476.8M -29.8% $-0.90 +28.0% 0.00% $-177.3M $-211.3M -152.8%
FY 2023 $627.1M -0.2% $147.0M $-1,452.7M -204.7% $-2.35 -161.1% 0.00% $7.9M $-12.9M +93.9%
FY 2024 $788.9M +25.8% $223.4M $-245.0M +83.1% $-0.33 +86.0% 0.00% $-30.9M $-60.2M -366.5%
FY 2025 $821.3M +4.1% $240.6M $-2,186.7M -792.6% $-2.46 -645.5% 0.00% $-94.6M $-127.5M -112.0%
FY 2026 $915.5M +11.5% $260.4M $-121.4M +94.4% $-1.09 +55.7% 0.00% $-69.1M $-102.1M +19.9%
$

Valuation

Market Price $4.53
Market Cap $526.50M
Enterprise Value $698.93M
P/E Ratio N/A
P/B Ratio 0.33
FCF Yield -19.40%
Dividend Yield N/A
Shares Outstanding 116,225,500
%

Profitability & Margins

Gross Margin 28.45%
Operating Margin -6.35%
Net Margin -13.26%
Return on Equity (ROE) -7.61%
Return on Assets (ROA) -5.21%
Asset Turnover 0.39x
Revenue 3-Yr CAGR 13.44%
🛡️

Financial Health & Liquidity

Current Ratio 14.70
Cash Ratio 51.36
Debt / Equity 0.250
Debt / Assets 0.171
Cash & Equivalents $225.98M
Total Debt $398.40M
Book Value / Share $13.72
💧

Cash Flow Efficiency

Operating Cash Flow -$69.14M
Capital Expenditures (CapEx) $32.99M
Free Cash Flow -$102.13M
OCF / Revenue -7.55%
FCF / Revenue -11.16%
FCF 3-Yr CAGR N/A
🏷️

Per Share Metrics

EPS (Diluted) $-1.09
EPS (Basic) $-1.09
Dividends / Share N/A
Book Value / Share $13.72
EPS YoY Growth 55.69%
🏛️

Balance Sheet (FY 2026)

Total Assets $2.33B
Total Liabilities $733.14M
Stockholders' Equity $1.59B
Current Assets $64.69M
Current Liabilities $4.40M